Related Experiment Video
Updated: Jun 11, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality]
1Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University.
Insights
Managing chronic kidney disease, mineral and bone disorder (CKD-MBD) is crucial for reducing mortality in uremic patients. Proper control of mineral levels, bone health, and vascular calcification significantly lowers death risk.
Area of Science:
- Nephrology
- Endocrinology
- Public Health
Background:
- Chronic kidney disease, mineral and bone disorder (CKD-MBD) is a complex condition in uremic patients.
- CKD-MBD management aims to reduce mortality, a primary concern in this population.
Purpose of the Study:
- To highlight the importance of managing laboratory and bone abnormalities, and vascular calcification in CKD-MBD.
- To review the impact of mineral metabolism control on mortality risk in uremic patients.
Main Methods:
- Review of observational studies and randomized clinical trials.
- Analysis of factors influencing mortality in CKD-MBD patients.
Main Results:
- Good control of serum phosphate, calcium, and parathyroid hormone (PTH) is associated with lower mortality.
- Fracture and vascular calcification are identified as significant risk factors for mortality.
- CKD-MBD therapies, including vitamin D and phosphate binders, may reduce mortality risk.
Conclusions:
- Effective management of CKD-MBD, focusing on mineral balance and bone health, is essential for improving survival in uremic patients.
- Addressing vascular calcification and fracture risk is critical for reducing mortality.
Abstract:
The final goal of CKD-MBD (chronic kidney disease, mineral and bone disorder) is to reduce the risk of death in uremic patients. To achieve this objective, it is of importance to manage laboratory abnormalities, bone abnormalities, and vascular calcification appropriately. Many observation studies suggested that the good control of serum phosphate, calcium, and PTH concentration would lead to the lower risk of death. Fracture and vascular calcification would increase the risk for mortality. In addition, some randomized clinical trials have shown that the use of CKD-MBD related drugs, e.g. vitamin D, phosphate binder, might lead to reductions in the risk of death.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury IV: Diagnostic Studies and Prevention
